Suman Srinivasa1, Kathleen V Fitch1, Kimberly Wong1, Martin Torriani1, Caitlin Mayhew1, Takara Stanley1, Janet Lo1, Gail K Adler1, Steven K Grinspoon1. 1. Program in Nutritional Metabolism (S.S., K.V.F., K.W., T.S., J.L., S.K.G.) and Division of Musculoskeletal Imaging and Intervention (M.T.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114; and Division of Endocrinology, Diabetes, and Hypertension (C.M., G.K.A.), Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115.
Abstract
CONTEXT: Little is known about renin-angiotensin-aldosterone system (RAAS) activation in relationship to visceral adipose tissue (VAT) accumulation in HIV-infected patients, a population at significant risk for insulin resistance and other metabolic disease. DESIGN: Twenty HIV and 10 non-HIV-infected subjects consumed a standardized low sodium or liberal sodium diet to stimulate or suppress the RAAS, respectively. RAAS parameters were evaluated in response to each diet and a graded angiotensin II infusion. Further analyses were performed after groups were substratified by median VAT measured by magnetic resonance imaging. RESULTS: Aldosterone concentrations during the low-sodium diet were higher in HIV than non-HIV-infected subjects [13.8 (9.7, 30.9) vs 9.2 (7.6, 13.6) ng/dL, P = .03] and increased across groups stratified by visceral adipose tissue (VAT) [8.5 (7.1, 12.8), 9.2 (8.1, 21.5), 11.4 (9.4, 13.8), and 27.2 (13.0, 36.9) ng/dL in non-HIV-infected without increased VAT, non-HIV-infected with increased VAT, HIV-infected without increased VAT, HIV-infected with increased VAT, respectively, overall trend P = .02]. Under this condition, plasma renin activity [3.50 (2.58, 4.65) vs 1.45 (0.58, 2.33) ng/mL · h, P = .002] was higher among the HIV-infected subjects with vs without increased VAT. Differences in the suppressibility of plasma renin activity by graded angiotensin infusion were seen stratifying by VAT among the HIV-infected group (P < .02 at each dose). In addition, aldosterone (P = .007) was an independent predictor of insulin resistance in multivariate modeling, controlling for VAT and adiponectin. CONCLUSION: These data suggest excess RAAS activation in relationship to visceral adiposity in HIV-infected patients that may independently contribute to insulin resistance. Mineralocorticoid blockade may have therapeutic potential to reduce metabolic complications in HIV-infected patients with increased visceral adiposity.
CONTEXT: Little is known about renin-angiotensin-aldosterone system (RAAS) activation in relationship to visceral adipose tissue (VAT) accumulation in HIV-infectedpatients, a population at significant risk for insulin resistance and other metabolic disease. DESIGN: Twenty HIV and 10 non-HIV-infected subjects consumed a standardized low sodium or liberal sodium diet to stimulate or suppress the RAAS, respectively. RAAS parameters were evaluated in response to each diet and a graded angiotensin II infusion. Further analyses were performed after groups were substratified by median VAT measured by magnetic resonance imaging. RESULTS: Aldosterone concentrations during the low-sodium diet were higher in HIV than non-HIV-infected subjects [13.8 (9.7, 30.9) vs 9.2 (7.6, 13.6) ng/dL, P = .03] and increased across groups stratified by visceral adipose tissue (VAT) [8.5 (7.1, 12.8), 9.2 (8.1, 21.5), 11.4 (9.4, 13.8), and 27.2 (13.0, 36.9) ng/dL in non-HIV-infected without increased VAT, non-HIV-infected with increased VAT, HIV-infected without increased VAT, HIV-infected with increased VAT, respectively, overall trend P = .02]. Under this condition, plasma renin activity [3.50 (2.58, 4.65) vs 1.45 (0.58, 2.33) ng/mL · h, P = .002] was higher among the HIV-infected subjects with vs without increased VAT. Differences in the suppressibility of plasma renin activity by graded angiotensin infusion were seen stratifying by VAT among the HIV-infected group (P < .02 at each dose). In addition, aldosterone (P = .007) was an independent predictor of insulin resistance in multivariate modeling, controlling for VAT and adiponectin. CONCLUSION: These data suggest excess RAAS activation in relationship to visceral adiposity in HIV-infectedpatients that may independently contribute to insulin resistance. Mineralocorticoid blockade may have therapeutic potential to reduce metabolic complications in HIV-infectedpatients with increased visceral adiposity.
Authors: Francesco Fallo; Paolo Della Mea; Nicoletta Sonino; Chiara Bertello; Mario Ermani; Roberto Vettor; Franco Veglio; Paolo Mulatero Journal: Am J Hypertens Date: 2007-08 Impact factor: 2.689
Authors: Sara E Dolan; Walter Frontera; Jamie Librizzi; Karin Ljungquist; Sandra Juan; Robert Dorman; Morgan E Cole; Jenna R Kanter; Steven Grinspoon Journal: Arch Intern Med Date: 2006-06-12
Authors: Jennifer L Kuk; Peter T Katzmarzyk; Milton Z Nichaman; Timothy S Church; Steven N Blair; Robert Ross Journal: Obesity (Silver Spring) Date: 2006-02 Impact factor: 5.002
Authors: Carl Grunfeld; David Rimland; Cynthia L Gibert; William G Powderly; Stephen Sidney; Michael G Shlipak; Peter Bacchetti; Rebecca Scherzer; Steven Haffner; Steven B Heymsfield Journal: J Acquir Immune Defic Syndr Date: 2007-11-01 Impact factor: 3.731
Authors: Christine Guo; Vincent Ricchiuti; Bill Q Lian; Tham M Yao; Patricia Coutinho; José R Romero; Jianmin Li; Gordon H Williams; Gail K Adler Journal: Circulation Date: 2008-04-21 Impact factor: 29.690
Authors: Julian Falutz; Soraya Allas; Koenraad Blot; Diane Potvin; Donald Kotler; Michael Somero; Daniel Berger; Stephen Brown; Gary Richmond; Jeffrey Fessel; Ralph Turner; Steven Grinspoon Journal: N Engl J Med Date: 2007-12-06 Impact factor: 91.245
Authors: Caitlin A Murphy; Kathleen V Fitch; Meghan Feldpausch; Patrick Maehler; Kimberly Wong; Martin Torriani; Gail K Adler; Steven K Grinspoon; Suman Srinivasa Journal: J Clin Endocrinol Metab Date: 2018-04-01 Impact factor: 5.958
Authors: Milana Bogorodskaya; Kathleen V Fitch; Tricia H Burdo; Patrick Maehler; Rebecca M Easly; Gillian R Murray; Meghan Feldpausch; Gail K Adler; Steven K Grinspoon; Suman Srinivasa Journal: J Infect Dis Date: 2019-09-26 Impact factor: 5.226
Authors: Suman Srinivasa; Anna Aulinas; Timothy O'Malley; Patrick Maehler; Gail K Adler; Steven K Grinspoon; Elizabeth A Lawson Journal: Am J Physiol Endocrinol Metab Date: 2018-06-26 Impact factor: 4.310
Authors: Chris deFilippi; Janet Lo; Robert Christenson; Ida Grundberg; Lauren Stone; Markella V Zanni; Hang Lee; Steven K Grinspoon Journal: AIDS Date: 2018-04-24 Impact factor: 4.177